CFDE Data Portal | Search MIR155HG

	Label	Description
	MIR155HG Gene (Entity type)	ENSG00000234883 - MIR155 host gene
	MIR155HG associations Collection (Entity type)	Associations for MIR155HG_associations
	MIR155HG associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE93156 idelalisib B cell 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171692 FXN knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176366 vincristine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 12 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

MIR155HG

ENSG00000234883 - MIR155 host gene

MIR155HG associations

Associations for MIR155HG_associations

MIR155HG associations.tsv

A file from IDG as part of the Harmonizome project

GSE93156 idelalisib B cell 1 v 0 human dn

A Gene Set from LINCS

GSE146982 metformin 4 v 2 human up

A Gene Set from LINCS

GSE171692 FXN knockdown 1 v 0 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE176366 vincristine 3 v 2 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 4 v 0 human dn

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 12 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.